Piperacetazine
 | |
| Clinical data | |
|---|---|
| Trade names | Actazine, Quide, Psymod |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C24H30N2O2S |
| Molar mass | 410.58 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Piperacetazine (Quide) is an antipsychotic prodrug, most notably used for schizophrenia.[1] It is a phenothiazine derivative. Based on clinical trial data, it appears to have similar efficacy as chlorpromazine. However, very little research has been done since the 1970s, and it is not a commonly used drug today.[2]
Side effects
[edit | edit source]The side effect profile of piperacetazine is similar to that of other typical antipsychotics. The most common side effects of piperacetazine are dizziness, drowsiness, fainting, orthostatic hypotension, and extrapyramidal symptoms. Less common side effects include nausea, vomiting, bradycardia, euphoria, and headache. Rare side effects include leukopenia, thrombocytopenia, galactorrhea, amenorrhea, seizures, urinary retention, and jaundice.[2]
References
[edit | edit source] | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |